| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |